Trial Information
Safety and Efficacy From Large Scale All Cases Surveillance for Etanercept in Japan
Inclusion Criteria
Inclusion Criteria
ยท Patients with rheumatoid arthritis [only those refractory to the previous treatment]
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Medical Monitor
Investigator Role:
Study Director
Investigator Affiliation:
Wyeth is now a wholly owned subsidiary of Pfizer
Authority:
Japan: Pharmaceuticals and Medical Devices Agency
Study ID:
0881Y1-4460
NCT ID:
NCT00503503
Start Date:
March 2005
Completion Date:
October 2007
Related Keywords:
- Rheumatoid Arthritis
- Arthritis
- Arthritis, Rheumatoid